Indication
Pathological gastric acid hypersecretory condition
A pathological gastric acid hypersecretory condition is a clinical disorder characterized by chronic, autonomous overproduction of gastric acid that substantially exceeds normal physiological requirements. Read more about Pathological gastric acid hypersecretory condition
502 drugs 204 manufacturers
Drugs that treat it
Common Pathological gastric acid hypersecretory condition therapies.
OMEPRAZOLE MAGNESIUM
PANTOPRAZOLE SODIUM-0.9% NACL (pantoprazole sodium in 0.9 % sodium chloride)
OMEPRAZOLE MAGNESIUM
PANTOPRAZOLE SODIUM
FAMOTIDINE
OMEPRAZOLE MAGNESIUM
ESOMEPRAZOLE MAGNESIUM
CIMETIDINE
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonA pathological gastric acid hypersecretory condition is a clinical disorder characterized by chronic, autonomous overproduction of gastric acid that substantially exceeds normal physiological requirements.
Primarily affecting the upper gastrointestinal tract, these conditions most commonly arise from underlying neuroendocrine or systemic disorders, such as gastrin-secreting neuroendocrine tumors in Zollinger-Ellison syndrome, systemic mastocytosis with hyperhistaminemia, or idiopathic gastric acid hypersecretion.
Pathophysiologically, persistent hyperstimulation of gastric parietal cells leads to severe hyperchlorhydria, which frequently manifests as refractory or recurrent peptic ulcer disease, severe erosive esophagitis, gastrointestinal bleeding, and secretory diarrhea.
- medicalnewstoday.com
A pathological gastric acid hypersecretory condition is a clinical disorder characterized by chronic, autonomous overproduction of gastric acid that substantially exceeds normal physiological requirements Primarily affecting the upper gastrointestinal tract, these conditions most commonly arise from underlying neuroendocrine or systemic disorders, such as gastrin-secreting neuroendocrine tumors in Zollinger-Ellison syndrome, systemic mastocytosis with hyperhistaminemia, or idiopathic gastric aci...
- nih.gov
A pathological gastric acid hypersecretory condition is a clinical disorder characterized by chronic, autonomous overproduction of gastric acid that substantially exceeds normal physiological requirements Primarily affecting the upper gastrointestinal tract, these conditions most commonly arise from underlying neuroendocrine or systemic disorders, such as gastrin-secreting neuroendocrine tumors in Zollinger-Ellison syndrome, systemic mastocytosis with hyperhistaminemia, or idiopathic gastric aci...
- nih.gov
Primarily affecting the upper gastrointestinal tract, these conditions most commonly arise from underlying neuroendocrine or systemic disorders, such as gastrin-secreting neuroendocrine tumors in Zollinger-Ellison syndrome, systemic mastocytosis with hyperhistaminemia, or idiopathic gastric acid hypersecretion
- nih.gov
Pathophysiologically, persistent hyperstimulation of gastric parietal cells leads to severe hyperchlorhydria, which frequently manifests as refractory or recurrent peptic ulcer disease, severe erosive esophagitis, gastrointestinal bleeding, and secretory diarrhea
- wjgnet.com
Pathophysiologically, persistent hyperstimulation of gastric parietal cells leads to severe hyperchlorhydria, which frequently manifests as refractory or recurrent peptic ulcer disease, severe erosive esophagitis, gastrointestinal bleeding, and secretory diarrhea
Personalize your experience
Follow Pathological gastric acid hypersecretory condition and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.